Pharmaceutical formulations of an HCV protease inhibitor in a solid molecular dispersion

Details for Australian Patent Application No. 2009279520 (hide)

Owner SCHERING CORPORATION

Inventors Sheth, Ashlesh; Hu, Chengjiu; Yue, Baohua; Omelczuk, Marcelo Osvaldo

Agent Griffith Hack

Pub. Number AU-A-2009279520

PCT Pub. Number WO2010/017432

Priority 61/086,997 07.08.08 US

Filing date 7 August 2009

Wipo publication date 11 February 2010

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 38/06 (2006.01) Medicinal preparations containing peptides - Tripeptides

Event Publications

24 February 2011 PCT application entered the National Phase

  PCT publication WO2010/017432 Priority application(s): WO2010/017432

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009279521-Use of sucralose as a granulating agent

2009279510-Solar energy conversion